You searched for "occlusion"
Visual prognosis in Irish Leber’s hereditary optic neuropathy
1 December 2022
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Leber’s hereditary optic neuropathy, idebenone, inherited optic neuropathy, mtDNA, ophthalmic genetics, optic atrophy
Leber’s hereditary optic neuropathy (LHON) is an inherited optic neuropathy This paper presents a retrospective review of clinical data from patients with LHON presenting to an Irish tertiary referral ophthalmic hospital. Clinical and genetic characteristics were assessed for useful biomarkers...
Using a driving simulator to explore the effect of visual field loss from optic disc drusen
3 April 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Traffic medicine, driving licence, legislation, optic disc drusen, visual field loss
The purpose of this study was to compare driving simulator performance of participants with visual field loss (VFL) from optic disc drusen (ODD) with a normally sighted control group and a group of individuals with glaucoma. Data on performance and...
Could idebenone by the solution for treating dominant optic atrophy?
3 September 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...
Conference report: SORD: Student Ophthalmology Review Day 2024
The Student Ophthalmology Review Day (SORD), now in its fifth year, was hosted at the Royal College of Ophthalmology at their esteemed London location, and two identical sessions were run on 11 and 12 December 2024. Designed for medical students...Prevalence of acute anterior uveitis in diabetic patients attending diabetic eye disease clinics
The authors share their investigation at Manchester Royal Eye Hospital into the association between diabetes and AAU. The global prevalence of diabetes mellitus (DM) is rapidly rising from an estimated 9.3% in 2019 to 10.2% by 2030 [1]. The link...You want to do paediatric ophthalmology? Seriously?
1 August 2017
| Ryan Davies
|
EYE - Neuro-ophthalmology
Completion of Core Training is approaching fast and you begin to wonder three things. One, where do you want to live? Two, is anyone going to be retiring there soon? Three, what subspecialty do you want to do? In an...
Patient care a family affair at Newcastle-Under-Lyme eye hospital
14 March 2022
With Mother’s Day just around the corner, mother and daughter Lisa Moors and Hannah Young won’t have to wait until next Sunday to spend time together - the pair work side-by-side, caring for hundreds of cataract surgery patients each week...
World Diabetes Day workshop highlights the importance of education to protect the sight of people living with diabetes
24 November 2022
Health professionals from all over the world came together to mark World Diabetes Day on 14 November 2022 through an online workshop celebrating progress in development of diabetic retinopathy (DR) services in low-and middle-income countries (LMICs).
SightCare 'The Future is Now' Conference a Success
14 February 2023
SightCare, the business support community for independent practices, was held on 29 and 30 January 2023 after its postponement from its original September date which unfortunately fell on the day of the Queen’s funeral.
Young visionaries win global competition by re-designing the Glasses of the Future
The International Agency for the Prevention of Blindness (IAPB) celebrated UNICEF World Children’s Day by announcing the winners of ‘Glasses of the Future’, a global competition that invited children across the world to design the next generation of glasses. Lama...
Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD
1 December 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...
RaScaL Study
1 June 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...
